Entries by

Freeline to Participate in Upcoming Investor Conferences

LONDON, July 31, 2023 – Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the company will be participating in two upcoming investor conferences in August. Details are as follows:  BTIG Virtual Biotechnology Conference   Freeline Chief Executive Officer Michael Parini will participate in a fireside chat at 10 a.m. ET on Monday, August 7. Management will […]